Robert W. Scherrer
Director of Finance/CFO at Genomas, Inc.
Profile
Robert W.
Scherrer is currently the Chief Financial Officer at Genomas, Inc. He previously worked as the President & Chief Operating Officer at Protein Sciences Corp.
from 1994 to 1998, as well as the Chief Financial Officer at Richardson-Vicks, Inc. He also served as the Chief Operating Officer & Senior Vice President at Freshnex, Inc. from 1999 to 2002.
Scherrer received his undergraduate degree from Temple University in Pennsylvania.
Robert W. Scherrer active positions
Companies | Position | Start |
---|---|---|
Genomas, Inc.
Genomas, Inc. Medical/Nursing ServicesHealth Services Genomas, Inc. operates as a biomedical company. It develops revolutionary PhyzioType Systems for DNA-guided management and prescription of drugs to treat mental illness, pain, heart disease, and diabetes. The firm’s products include HILOmet PhyzioType System, PIMS PhyzioType, SINM PhyzioType, and GLIM PhyzioType systems. The company was founded by Gualberto Ruaño in 2004 and is headquartered in Hartford, CT. | Director of Finance/CFO | - |
Former positions of Robert W. Scherrer
Companies | Position | End |
---|---|---|
Freshnex, Inc. | Chief Operating Officer | 31/12/2001 |
Protein Sciences Corp.
Protein Sciences Corp. BiotechnologyHealth Technology Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT. | President | 31/12/1997 |
Richardson-Vicks, Inc. | Director of Finance/CFO | - |
Training of Robert W. Scherrer
Temple University (Pennsylvania) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Genomas, Inc.
Genomas, Inc. Medical/Nursing ServicesHealth Services Genomas, Inc. operates as a biomedical company. It develops revolutionary PhyzioType Systems for DNA-guided management and prescription of drugs to treat mental illness, pain, heart disease, and diabetes. The firm’s products include HILOmet PhyzioType System, PIMS PhyzioType, SINM PhyzioType, and GLIM PhyzioType systems. The company was founded by Gualberto Ruaño in 2004 and is headquartered in Hartford, CT. | Health Services |
Protein Sciences Corp.
Protein Sciences Corp. BiotechnologyHealth Technology Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT. | Health Technology |
Richardson-Vicks, Inc. | |
Freshnex, Inc. |
- Stock Market
- Insiders
- Robert W. Scherrer